SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Clinical trials for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 explained in plain language.
Never miss a new study
Get alerted when new SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 trials appear
Sign up with your email to follow new studies for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New COVID-19 vaccine trial for kids aims to boost protection against variants
⭐️ VACCINE ⭐️ OngoingThis study is testing a new version of the COVID-19 vaccine that is designed to work better against newer virus variants. It includes over 4,000 healthy children from 6 months to 12 years old, some who have had prior COVID-19 vaccines and some who have not. The goal is to see if …
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:34 UTC
-
Severe COVID-19 lung scarring: how common and who is at risk?
Knowledge-focused OngoingThis study looks at 200 people with severe COVID-19 who needed intensive care to see how often they develop lung scarring (pulmonary fibrosis). Researchers will track their recovery, including time off a breathing machine and survival at 90 days, to understand risk factors and ou…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated May 26, 2026 09:00 UTC